Skip to main content
Top

26-04-2024 | Editorial

Direct-to-Consumer Pharmacies: Disruptive Innovation or More Complexity?

Author: Ravi Gupta, MD, MS

Published in: Journal of General Internal Medicine

Login to get access

Excerpt

In recent years, direct-to-consumer (DTC) pharmacies have been among the newest entrants in the United States’ byzantine pharmaceutical system. Unlike retail pharmacies, characterized by opaque prices, DTC pharmacies allow patients to view prices and purchase prescription generic drugs without the use of health insurance. The DTC pharmacies—of which there are now many—may serve as an important option for those who face difficulty affording medications at retail pharmacies, such as patients who lack insurance or incur high out-of-pocket costs through their insurance. However, whether DTC pharmacies are a disruptive innovation or simply add another layer of complexity for clinicians and patients remains unclear. …
Literature
7.
go back to reference Cortese BD, Dusetzina SB, Luckenbaugh AN, Al Hussein Al Awamlh B, Stimson CJ, Barocas DA, et al. Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare. J Clin Oncol. 2023;41(29):4664-8. https://doi.org/10.1200/JCO.23.00079 Cortese BD, Dusetzina SB, Luckenbaugh AN, Al Hussein Al Awamlh B, Stimson CJ, Barocas DA, et al. Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare. J Clin Oncol. 2023;41(29):4664-8. https://​doi.​org/​10.​1200/​JCO.​23.​00079
Metadata
Title
Direct-to-Consumer Pharmacies: Disruptive Innovation or More Complexity?
Author
Ravi Gupta, MD, MS
Publication date
26-04-2024
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-024-08729-3
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.